in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization


* Department of Ophthalmology, Kyushu University Graduate School of Medicine, Fukuoka, Japan; and
Department of Ophthalmology & Visual Sciences, W.K. Kellogg Eye Center, University of Michigan, Ann Arbor
Correspondence: Shigeo Yoshida, M.D., Ph.D., Department of Ophthalmology, Kyushu University Graduate School of Medicine, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan. E-mail: usyosi{at}yahoo.com
Macrophages are important participants in neovascularization. This study was designed to examine the role of the monocyte/macrophage chemotactic proteins, monocyte chemotactic protein-1 (MCP-1), and macrophage inflammatory protein-1
(MIP-1
) in a mouse model of oxygen-induced ischemic retinopathy and to determine whether the morphology and distribution of macrophages/microglia are concomitantly altered. The MCP-1, MIP-1
mRNA levels increased at 3 h after ischemia. MCP-1, MIP-1
, and vascular endothelial growth factor protein levels were also increased markedly and were maximal on days 1, 0.5, and 1, respectively, after ischemia. In situ hybridization showed that MCP-1 and MIP-1
were localized in the hypoxic inner retina. Immunostaining demonstrated that the macrophages/microglia in the retina had morphological changes with enlarged processes, and some were closely associated with neovascular tufts at postnatal day 17. Coadministration of the neutralizing antibodies against MCP-1 and MIP-1
inhibited retinal neovascularization by 30%. Our data suggest that MCP-1 and MIP-1
are involved in the induction of retinal neovascularization and play a role in the inflammation induced by the ischemic retinopathy, possibly by modulating or attracting macrophages/microglia.
Key Words: cytokines macrophages retinal ischemia angiogenesis
This article has been cited by other articles:
![]() |
W. Zhang, M. Rojas, B. Lilly, N.-T. Tsai, T. Lemtalsi, G. I. Liou, R. W. Caldwell, and R. B. Caldwell NAD(P)H Oxidase-Dependent Regulation of CCL2 Production during Retinal Inflammation Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 3033 - 3040. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Joly, M. Samardzija, A. Wenzel, M. Thiersch, and C. Grimm Nonessential Role of {beta}3 and {beta}5 Integrin Subunits for Efficient Clearance of Cellular Debris after Light-Induced Photoreceptor Degeneration Invest. Ophthalmol. Vis. Sci., March 1, 2009; 50(3): 1423 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Wilkinson-Berka, G. Tan, K. Jaworski, and A. G. Miller Identification of a Retinal Aldosterone System and the Protective Effects of Mineralocorticoid Receptor Antagonism on Retinal Vascular Pathology Circ. Res., January 2, 2009; 104(1): 124 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Sato, S Kusaka, N Hashida, Y Saishin, T Fujikado, and Y Tano Comprehensive gene-expression profile in murine oxygen-induced retinopathy Br. J. Ophthalmol., January 1, 2009; 93(1): 96 - 103. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ning, J. Cui, E. To, K. H. Ashe, and J. Matsubara Amyloid-{beta} Deposits Lead to Retinal Degeneration in a Mouse Model of Alzheimer Disease Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 5136 - 5143. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. X Zhang, J. J Wang, A. Dashti, K. Wilson, M.-H. Zou, L. Szweda, J.-X. Ma, and T. J Lyons Pigment epithelium-derived factor mitigates inflammation and oxidative stress in retinal pericytes exposed to oxidized low-density lipoprotein J. Mol. Endocrinol., September 1, 2008; 41(3): 135 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Davies, A. J. Stempel, and M. R. Powers MCP-1 Deficiency Delays Regression of Pathologic Retinal Neovascularization in a Model of Ischemic Retinopathy Invest. Ophthalmol. Vis. Sci., September 1, 2008; 49(9): 4195 - 4202. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Yamaji, S. Yoshida, K. Ishikawa, A. Sengoku, K. Sato, A. Yoshida, R. Kuwahara, K. Ohuchida, E. Oki, H. Enaida, et al. TEM7 (PLXDC1) in Neovascular Endothelial Cells of Fibrovascular Membranes from Patients with Proliferative Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., July 1, 2008; 49(7): 3151 - 3157. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Yamada, E. Sakurai, M. Itaya, S. Yamasaki, and Y. Ogura Inhibition of Laser-Induced Choroidal Neovascularization by Atorvastatin by Downregulation of Monocyte Chemotactic Protein-1 Synthesis in Mice Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1839 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Satofuka, A. Ichihara, N. Nagai, T. Koto, H. Shinoda, K. Noda, Y. Ozawa, M. Inoue, K. Tsubota, H. Itoh, et al. Role of Nonproteolytically Activated Prorenin in Pathologic, but Not Physiologic, Retinal Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 422 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakayama, N. Mutsuga, L. Yao, and G. Tosato Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells J. Leukoc. Biol., January 1, 2006; 79(1): 95 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Meleth, E. Agron, C.-C. Chan, G. F. Reed, K. Arora, G. Byrnes, K. G. Csaky, F. L. Ferris III, and E. Y. Chew Serum Inflammatory Markers in Diabetic Retinopathy Invest. Ophthalmol. Vis. Sci., November 1, 2005; 46(11): 4295 - 4301. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Nagai, K. Noda, T. Urano, Y. Kubota, H. Shinoda, T. Koto, K. Shinoda, M. Inoue, T. Shiomi, E. Ikeda, et al. Selective Suppression of Pathologic, but Not Physiologic, Retinal Neovascularization by Blocking the Angiotensin II Type 1 Receptor Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 1078 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Elner, V. M. Elner, A. Yoshida, R. D. Dick, and G. J. Brewer Effects of Tetrathiomolybdate in a Mouse Model of Retinal Neovascularization Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 299 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-M. Bian, S. G. Elner, A. Yoshida, and V. M. Elner Differential Involvement of Phosphoinositide 3-Kinase/Akt in Human RPE MCP-1 and IL-8 Expression Invest. Ophthalmol. Vis. Sci., June 1, 2004; 45(6): 1887 - 1896. [Abstract] [Full Text] [PDF] |
||||